|
| | February 28, 2019 | |
| | |
| | The latest antibodies news from News Medical | |
|
|
| | High-Affinity CD19 for CAR-T Cell Therapy
CD19 still remains the strongest contender in CAR-T cell therapy. According to ClinicalTrials.gov, over 600 CAR T cell clinical trials have been carried out to date, a majority of which aiming to treat leukemia or lymphoma patients using CD19‐specific CARs.
| |
|
|
|
|
 |
| | Researchers have engineered "antibody-like" T cell receptors that can specifically stick to cells infected with cytomegalovirus, or CMV, a virus that causes lifelong infection in more than half of all adults by age 40. | |
|
| | In the quest to develop an effective HIV vaccine, researchers have focused attention on identifying and targeting the region of the virus's outer envelope where a lineage of antibodies are able to dock and neutralize the virus. | |
|
| | A review of TUNEL staining kits and an overview of the processes involved in TUNEL staining. | |
|
| | ChIP-seq has several advantages over previous methods, such as ChIP-chip, but like many techniques, ChIP-seq is limited by access and cost. | |
|
|
|
|
No hay comentarios:
Publicar un comentario